These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14740967)

  • 21. Anticoagulation and atrial fibrillation.
    Atwood JE; Albers GW
    Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants.
    Hankey GJ
    Thromb Haemost; 2014 May; 111(5):808-16. PubMed ID: 24285341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial.
    Jaspers Focks J; Brouwer MA; Wojdyla DM; Thomas L; Lopes RD; Washam JB; Lanas F; Xavier D; Husted S; Wallentin L; Alexander JH; Granger CB; Verheugt FW
    BMJ; 2016 Jun; 353():i2868. PubMed ID: 27306620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?
    Wong CW
    Hong Kong Med J; 2016 Dec; 22(6):608-15. PubMed ID: 27920399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of stroke in patients with atrial fibrillation.
    Olsson SB; Halperin JL
    Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation.
    Man-Son-Hing M; Laupacis A
    Arch Intern Med; 2002 Mar; 162(5):541-50. PubMed ID: 11871922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How do family medicine residents choose an anticoagulation regimen for patients with nonvalvular atrial fibrillation?
    Yazdan-Ashoori P; Oqab Z; McIntyre WF; Quinn KL; Oosten EV; Hopman WM; Baranchuk A
    Prim Health Care Res Dev; 2017 Sep; 18(5):472-481. PubMed ID: 28464979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke.
    Yoon CH; Park YK; Kim SJ; Lee MJ; Ryoo S; Kim GM; Chung CS; Lee KH; Kim JS; Bang OY
    Stroke; 2014 Oct; 45(10):2983-8. PubMed ID: 25147329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To anticoagulate or not to anticoagulate? A common dilemma for the provider: physicians' opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation.
    Dharmarajan TS; Varma S; Akkaladevi S; Lebelt AS; Norkus EP
    J Am Med Dir Assoc; 2006 Jan; 7(1):23-8. PubMed ID: 16413431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude.
    Bahri O; Roca F; Lechani T; Druesne L; Jouanny P; Serot JM; Boulanger E; Puisieux F; Chassagne P
    J Am Geriatr Soc; 2015 Jan; 63(1):71-6. PubMed ID: 25597559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
    Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
    Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.
    Go AS; Hylek EM; Borowsky LH; Phillips KA; Selby JV; Singer DE
    Ann Intern Med; 1999 Dec; 131(12):927-34. PubMed ID: 10610643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients.
    Gallagher AM; Setakis E; Plumb JM; Clemens A; van Staa TP
    Thromb Haemost; 2011 Nov; 106(5):968-77. PubMed ID: 21901239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
    Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
    Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges of anticoagulation for atrial fibrillation in patients with severe sepsis.
    Darwish OS; Strube S; Nguyen HM; Tanios MA
    Ann Pharmacother; 2013 Oct; 47(10):1266-71. PubMed ID: 24259690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin.
    Senoo K; Lip GY
    Stroke; 2016 Jun; 47(6):1665-8. PubMed ID: 27125527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.
    Janzic A; Kos M
    Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.